Cesar Perez: During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents for Head and Neck Cancer

Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and Research Institute, shared on LinkedIn:

“Drug Development for patients with Head and Neck Cancer has lagged behind over the last decade.

However, a new era is approaching.

During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents in development for the disease, which will bring hope for a population in so much need for new options.

‘Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy’.”

Source: Cesar Perez/LinkedIn